PARK CIRCLE Co Purchases 300 Shares of CVS Health Co. (NYSE:CVS)

PARK CIRCLE Co boosted its position in CVS Health Co. (NYSE:CVS) by 42.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,000 shares of the pharmacy operator’s stock after buying an additional 300 shares during the period. PARK CIRCLE Co’s holdings in CVS Health were worth $45,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the company. Arete Wealth Advisors LLC acquired a new position in shares of CVS Health during the 3rd quarter valued at $1,369,000. Morse Asset Management Inc acquired a new position in shares of CVS Health during the third quarter valued at about $409,000. Quantinno Capital Management LP boosted its position in shares of CVS Health by 67.2% during the 3rd quarter. Quantinno Capital Management LP now owns 64,489 shares of the pharmacy operator’s stock worth $4,055,000 after purchasing an additional 25,925 shares in the last quarter. Texas Capital Bank Wealth Management Services Inc bought a new stake in CVS Health in the 3rd quarter valued at about $278,000. Finally, Weiss Asset Management LP acquired a new position in CVS Health during the 3rd quarter worth approximately $6,614,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 5.9 %

CVS stock opened at $63.54 on Friday. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $74.85. The stock has a fifty day moving average of $63.47 and a 200-day moving average of $58.01. The company has a market capitalization of $80.11 billion, a price-to-earnings ratio of 17.36, a PEG ratio of 0.98 and a beta of 0.57. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, equities research analysts predict that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.19%. The ex-dividend date is Tuesday, April 22nd. CVS Health’s payout ratio is currently 72.68%.

Insider Activity

In related news, SVP James David Clark sold 7,513 shares of the company’s stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares of the company’s stock, valued at approximately $556,941.90. This represents a 47.23 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Michael F. Mahoney bought 30,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the purchase, the director now directly owns 39,356 shares in the company, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.24% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of research reports. Barclays boosted their price objective on CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. Wells Fargo & Company upped their price objective on shares of CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a report on Thursday, February 13th. Edward Jones upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Wolfe Research upped their target price on shares of CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a report on Tuesday, February 11th. Finally, Evercore ISI lifted their price target on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research note on Monday, January 27th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $70.39.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.